In this webinar, Peter Hunt and Matthew Segall examine the effective use of QSAR modelling in drug discovery and discuss a variety of pain points for medicinal chemists in knowing when a model can be trusted and how to avoid common pitfalls. We discuss key learning points for the successful use of QSAR models and how they can be used to make better decisions in a multi-parameter optimisation workflow to select and design high-quality compounds for your projects.

Topics for discussion include:

  • What is a QSAR model?
  • How do you assess and compare models?
  • The limitations of data for modelling and validation
  • Where can I use a model? Local vs Global models
  • How can I make the best use of imperfect models?
  • How do I know if a model prediction is good enough to use in practice?
  • Effectively guiding compound design

Meet the speakers

Matt Segall, PhD

CEO, Optibrium

Profile

The image shows Optibrium CEO Matthew Segall

Peter Hunt, PhD

Director Computational Chemistry, Optibrium

Profile

Peter Hunt, PhD

Other webinars you may be interested in